UK position in global clinical trials sector could receive boost after Covid-19

29th May 2020 (Last Updated May 29th, 2020 12:14)

The UK’s efforts to find vaccines and treatments for Covid-19 could elevate its status in the clinical trials sector, says an industry boss.

Cross-industry partnerships featuring UK-based pharma firms, government departments and hospitals are also “massively important” in tackling the crisis, said Tim Sheppard, general manager for Northern Europe at clinical research company IQVIA.

The University of Oxford is currently working with UK pharma giant AstraZeneca to test and develop a potential coronavirus vaccine, while the RECOVERY trial is one of the world’s largest clinical studies for Covid-19 treatments, testing drug therapies in multiple locations across the country.

Read the full article here.